🇺🇸 Rotigotine patch in United States

28 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 28

Most-reported reactions

1. Anxiety — 4 reports (14.29%)
2. Depression — 4 reports (14.29%)
3. On And Off Phenomenon — 4 reports (14.29%)
4. Gait Inability — 3 reports (10.71%)
5. Gambling Disorder — 3 reports (10.71%)
6. Middle Insomnia — 3 reports (10.71%)
7. Muscle Spasms — 3 reports (10.71%)
8. Unresponsive To Stimuli — 2 reports (7.14%)
9. Abdominal Pain — 1 report (3.57%)
10. Acute Kidney Injury — 1 report (3.57%)

Source database →

Frequently asked questions

Is Rotigotine patch approved in United States?

Rotigotine patch does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Rotigotine patch in United States?

UCB Pharma is the originator. The local marketing authorisation holder may differ — check the official source linked above.